Table 1 Patient characteristics and outcomes (n = 63)
Variable | Â |
|---|---|
Age in years, median (P25–75) | 70 (60–75) |
Age group, n (%) | Â |
   ≥ 65 years | 43 (68) |
   < 65 years | 20 (32) |
Sex, n (%) | Â |
   Male | 48 (76) |
   Female | 15 (24) |
Body Mass Index in Kg/m2, median (P25–P75) | 25 (24–28) |
General anesthesia/Regional anesthesia, n. (%) | 24 (38)/39 (62) |
Duration of anesthesia (min.) median (P25–P75) | 160 (140–180) |
Temperature at admission on PACU, mean ± sd | 35.8 ± 0.81 |
Troponin I at admission, mean ± sd | 0.027 ± 0.22 |
Hypertension, n (%) | 60 (95) |
Hyperlipidemia, n (%) | 53 (84) |
Ischemic heart disease, n (%) | 41 (65) |
Congestive heart disease, n (%) | 5 (8) |
Cerebrovascular disease, n (%) | 34 (54) |
Insulin therapy for diabetes, n (%) | 3 (5) |
Preoperative serum creatinine > 2 mg/dl | 1 (2) |
Total RCRI, mean ± sd | 1.35 ± 0.85 |
High-risk patients, n (%) | 14 (22.2) |
Neurological evaluation | Â |
   Asymptomatic | 13 (21) |
   Severe bilateral carotid disease | 19 (30) |
   Amaurosis | 4 (6) |
   Transient ischaemic attack | 15 (24) |
   Stroke with full recovery | 6 (10) |
   Stroke with residual deficit | 13 (21) |
Katz scale, mean ± sd | 0.22 ± 0.72 |
Dependency in I-ADL, n (%) | 7 (11) |
Lawton I-ADL scale, mean ± sd | 6.1 ± 1.9 |
Dependency in P-ADL, n (%) | 14 (22) |
SAPS II, median (P25–75) | 16 (12–21) |
APACHE II, median (P25–75) | 7 (6–10) |
PACU length of stay (hours), median (P25–75) | 21 (16–22) |
Hospital length of stay (days), median (P25–75) | 5 (4–7) |
Mortality in PACU, n (%) | 0 (0) |
Mortality in hospital, n (%) | 3 (4.8) |